Heavy dependent nicotine smokers – Newfound lifestyle appreciation after quitting successfully. Experiences from inpatient smoking cessation therapy

Schoberberger, Rudolf; Böhm, Gabriela; Schroeder, Y

doi:10.1016/j.puhe.2015.02.011

Cited by 10 publications

(20 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These results are consistent with evidence from our uncontrolled pilot study that found 6-month abstinence rates of 50% for a residential smoking cessation therapy [44]. Comparatively high abstinence rates of up to 12 months have been reported in an American study with a 7-day residential smoking cessation (57% [40]) and in studies from Austria implementing a 21-day residential format (63.3% and 42.6% in studies with heavily dependent smokers [42,43]), but with all studies missing control groups. Lastly, a 5-day stepwise residential nicotine cessation program has shown satisfactory abstinence rates of 31% at follow-up exceeding 2 years, even when counting participants who could not be reached as smoking [41].…”

Section: Background and Rationale {6a}supporting

confidence: 90%

“…These relate to uncontrolled or cohort studies with limited methodological quality. However, outcomes suggest significantly increased 6-month or 12-month abstinence rates from 42.6 to 64.7% [21,[38][39][40][41][42][43]. In a large American cohort study with 226 residential smokers, Hays et al [21] reported significantly higher 6-month abstinence rates of 52% from 8-day residential smoking cessation therapy directly compared to 27% in outpatient therapy with 4327 patients, conducted from the same research group.…”

Section: Background and Rationale {6a}mentioning

confidence: 99%

“…Post-trial care is not intended: no specific risks have been reported regarding participation in residential or outpatient smoking cessation therapies [40,42,47]. Both treatment groups have access to standard healthcare treatment.…”

Section: Provisions For Post-trial Care {30}mentioning

confidence: 99%

“…Residential smoking cessation programs have been shown to be safe in various contexts. Although no particular adverse effects of smoking cessation provided in a residential setting have been reported [40,42], nicotine withdrawal symptoms [57] and adverse effects of therapy will be carefully protocolled, such as deterioration of mood and sleep.…”

Section: Quality Of Lifementioning

confidence: 99%

See 3 more Smart Citations

Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy (‘START-Study’): study protocol of a randomized controlled trial

Dickreuter

Schmoor

Bengel³

et al. 2020

Trials

View full text Add to dashboard Cite

Background: In Germany, evidence-based outpatient smoking cessation therapies are widely available. Long-term abstinence rates, however, are limited. Studies suggest that short-term residential therapy enables a higher level of environmental control, more intense contact and greater support among patients and from therapists, which could result in higher abstinence rates. The aim of the current START-study is to investigate the long-term efficacy of a short-term residential therapy exclusively for smoking cessation, conducted by a mobile team of expert therapists. Methods: A randomized controlled trial (RCT) is conducted to examine the efficacy of residential behavior therapeutic smoking cessation therapy compared to standard outpatient behavior therapeutic smoking cessation group therapy. Adult smokers consuming 10 or more cigarettes per day, who are willing to stop smoking, are randomized in a ratio of 1:1 between therapy groups. The primary endpoint is sustained abstinence for 6-month and 12-month periods. Secondary endpoints include smoking status after therapy, 7-day point abstinence after the 6-month and 12-month follow-ups, level of physical dependence, cost-effectiveness, use of nicotine replacement products, health-related quality of life, self-efficacy expectation for tobacco abstinence, motivational and volitional determinants of behavior change, self-reported depressive symptom severity, adverse events and possible side effects. Assessments will take place at baseline, post-therapy, and at 6-month and 12-month intervals after smoking cessation. Discussion: There is a high demand for long-term effective smoking cessation therapies. This study represents the first prospective RCT to examine the long-term efficacy of a residential smoking cessation therapy program compared to standard outpatient group therapy as an active control condition. The residential therapeutic concept may serve as a new model to substantially enhance future cessation therapies and improve the understanding of therapeutic impact factors on tobacco abstinence. Utilizing a mobile team, the model could be applied efficiently to medical centers that do not have permanent and trained personnel for smoking cessation at their disposal.

show abstract

Section: Background and Rationale {6a}supporting

confidence: 90%

Section: Background and Rationale {6a}mentioning

confidence: 99%

Section: Provisions For Post-trial Care {30}mentioning

confidence: 99%

Section: Quality Of Lifementioning

confidence: 99%

See 2 more Smart Citations

Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy (‘START-Study’): study protocol of a randomized controlled trial

Dickreuter

Schmoor

Bengel³

et al. 2020

Trials

View full text Add to dashboard Cite

show abstract

“…This can be characteristics of smoking behavior, motivation to quit, or characteristics of special populations. There is some data to suggest that heavy or highly dependent smokers can benefit from higher dose of NRT [6] or more intensive interventions [17] as suggested by 3-week inpatient intervention for heavy smokers. Nicotine metabolism rate varies between individuals is influenced by genomic and hormonal factors and may result in variation in smoking behavior and response to smoking cessation therapy.…”

Section: Targeted and Individualized Therapiesmentioning

confidence: 99%